|
Volume 270,
Number 45,
Issue of November 10, 1995 pp. 26762-26765
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Cloning
and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic
Polypeptide, Neuropeptide Y, and Peptide YY
(Received for publication, August 18, 1995; and in revised form, September 5, 1995)
Jonathan A.
Bard ,
Mary W.
Walker,
Theresa
A.
Branchek,
Richard L.
Weinshank
The pancreatic polypeptide family includes pancreatic
polypeptide (PP), neuropeptide Y (NPY), and peptide YY (PYY). Members
of the PP family regulate numerous physiological processes, including
appetite, gastrointestinal transit, anxiety, and blood pressure. Of the
multiple Y-type receptors proposed for PP family members, only the Y1
subtype has been cloned previously. We now report the cloning of an
additional Y-type receptor, designated Y4, by homology screening of a
human placental genomic library with transmembrane (TM) probes derived
from the rat Y1 gene. The Y4 genomic clone encodes a predicted protein
of 375 amino acids that is most homologous to Y1 receptors from human,
rat, and mouse (42% overall; 55% in TM). I-PYY binding to
transiently expressed Y4 receptors was saturable (pK = 9.89) and displaceable by human PP family
derivatives: PP (pK = 10.25)
PP (pK =
10.06) > PYY (pK = 9.06)
[Leu ,Pro ]NPY (pK = 8.95) > NPY (pK = 8.68) > PP (pK = 7.13) >
PP (pK =
6.46) > PP free acid (pK < 5). Human PP decreased [cAMP] and increased
intracellular [Ca ] in Y4-transfected
LMTK cells. Y4 mRNA was detected by reverse
transcriptase-polymerase chain reaction in human brain, coronary
artery, and ileum, suggesting potential roles for Y4 receptors in
central nervous system, cardiovascular, and gastrointestinal function.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Kamiji and A. Inui
Neuropeptide Y Receptor Selective Ligands in the Treatment of Obesity
Endocr. Rev.,
October 1, 2007;
28(6):
664 - 684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Merten, D. Lindner, N. Rabe, H. Rompler, K. Morl, T. Schoneberg, and A. G. Beck-Sickinger
Receptor Subtype-specific Docking of Asp6.59 with C-terminal Arginine Residues in Y Receptor Ligands
J. Biol. Chem.,
March 9, 2007;
282(10):
7543 - 7551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Acuna-Goycolea, N. Tamamaki, Y. Yanagawa, K. Obata, and A. N. van den Pol
Mechanisms of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Inhibition of Identified Green Fluorescent Protein-Expressing GABA Neurons in the Hypothalamic Neuroendocrine Arcuate Nucleus
J. Neurosci.,
August 10, 2005;
25(32):
7406 - 7419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Seda, F. Liska, D. Krenova, L. Kazdova, L. Sedova, T. Zima, J. Peng, K. Pelinkova, J. Tremblay, P. Hamet, et al.
Dynamic genetic architecture of metabolic syndrome attributes in the rat
Physiol Genomics,
April 14, 2005;
21(2):
243 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bonaventure, D. Nepomuceno, C. Mazur, B. Lord, D. A. Rudolph, J. A. Jablonowski, N. I. Carruthers, and T. W. Lovenberg
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a Small Molecule Antagonist of the Neuropeptide Y Y2 Receptor
J. Pharmacol. Exp. Ther.,
March 1, 2004;
308(3):
1130 - 1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Berglund, D. A. Schober, M. A. Esterman, and D. R. Gehlert
Neuropeptide Y Y4 Receptor Homodimers Dissociate upon Agonist Stimulation
J. Pharmacol. Exp. Ther.,
December 1, 2003;
307(3):
1120 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sainsbury, P. A. Baldock, C. Schwarzer, N. Ueno, R. F. Enriquez, M. Couzens, A. Inui, H. Herzog, and E. M. Gardiner
Synergistic Effects of Y2 and Y4 Receptors on Adiposity and Bone Mass Revealed in Double Knockout Mice
Mol. Cell. Biol.,
August 1, 2003;
23(15):
5225 - 5233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Campbell, K. L. Grove, and M. S. Smith
Gonadotropin-Releasing Hormone Neurons Coexpress Orexin 1 Receptor Immunoreactivity and Receive Direct Contacts by Orexin Fibers
Endocrinology,
April 1, 2003;
144(4):
1542 - 1548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Berglund, P. A. Hipskind, and D. R. Gehlert
Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes
Experimental Biology and Medicine,
March 1, 2003;
228(3):
217 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Campbell, M. S. Smith, S. E. Allen, B. E. Grayson, J. M. H. ffrench-Mullen, and K. L. Grove
Orexin Neurons Express a Functional Pancreatic Polypeptide Y4 Receptor
J. Neurosci.,
February 15, 2003;
23(4):
1487 - 1497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sainsbury, C. Schwarzer, M. Couzens, A. Jenkins, S. R. Oakes, C. J. Ormandy, and H. Herzog
Y4 receptor knockout rescues fertility in ob/ob mice
Genes & Dev.,
May 1, 2002;
16(9):
1077 - 1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Proske, M. Hofliger, R. M. Soll, A. G. Beck-Sickinger, and M. Famulok
A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y
J. Biol. Chem.,
March 22, 2002;
277(13):
11416 - 11422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cavadas, A. P. Silva, F. Mosimann, M. D. Cotrim, C. A. F. Ribeiro, H. R. Brunner, and E. Grouzmann
NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells
J. Clin. Endocrinol. Metab.,
December 1, 2001;
86(12):
5956 - 5963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mullins, D. Kirby, J. Hwa, M. Guzzi, J. Rivier, and E. Parker
Identification of Potent and Selective Neuropeptide Y Y1 Receptor Agonists with Orexigenic Activity in Vivo
Mol. Pharmacol.,
September 1, 2001;
60(3):
534 - 540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Furtinger, S. Pirker, T. Czech, C. Baumgartner, G. Ransmayr, and G. Sperk
Plasticity of Y1 and Y2 Receptors and Neuropeptide Y Fibers in Patients with Temporal Lobe Epilepsy
J. Neurosci.,
August 1, 2001;
21(15):
5804 - 5812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Goumain, T. Voisin, A.-M. Lorinet, R. Ducroc, A. Tsocas, C. Roze, P. Rouet-Benzineb, H. Herzog, A. Balasubramaniam, and M. Laburthe
The Peptide YY-Preferring Receptor Mediating Inhibition of Small Intestinal Secretion Is a Peripheral Y2 Receptor: Pharmacological Evidence and Molecular Cloning
Mol. Pharmacol.,
July 1, 2001;
60(1):
124 - 134.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. A. Schober, S. L. Gackenheimer, M. L. Heiman, and D. R. Gehlert
Pharmacological Characterization of 125I-1229U91 Binding to Y1 and Y4 Neuropeptide Y/Peptide YY Receptors
J. Pharmacol. Exp. Ther.,
April 1, 2000;
293(1):
275 - 280.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. L. nbecher, C. B. Foster, S. Zhu, D. Venzon, S. M. Steinberg, K. Wyvill, J. A. Metcalf, S. S. Cohen, J. Kovacs, R. Yarchoan, et al.
Variant genotypes of Fcgamma RIIIA influence the development of Kaposi's sarcoma in HIV-infected men
Blood,
April 1, 2000;
95(7):
2386 - 2390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kanatani, S. Mashiko, N. Murai, N. Sugimoto, J. Ito, T. Fukuroda, T. Fukami, N. Morin, D. J. MacNeil, L. H. T. Van der Ploeg, et al.
Role of the Y1 Receptor in the Regulation of Neuropeptide Y-Mediated Feeding: Comparison of Wild-Type, Y1 Receptor-Deficient, and Y5 Receptor-Deficient Mice
Endocrinology,
March 1, 2000;
141(3):
1011 - 1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Y. Ho, A. G. Beck-Sickinger, and W. F. Colmers
Neuropeptide Y5 Receptors Reduce Synaptic Excitation in Proximal Subiculum, But Not Epileptiform Activity in Rat Hippocampal Slices
J Neurophysiol,
February 1, 2000;
83(2):
723 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Voisin, M. Goumain, A.-M. Lorinet, J.-J. Maoret, and M. Laburthe
Functional and Molecular Properties of the Human Recombinant Y4 Receptor: Resistance to Agonist-Promoted Desensitization
J. Pharmacol. Exp. Ther.,
February 1, 2000;
292(2):
638 - 646.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Lehrnbecher, C. B. Foster, S. Zhu, S. F. Leitman, L. R. Goldin, K. Huppi, and S. J. Chanock
Variant Genotypes of the Low-Affinity Fcgamma Receptors in Two Control Populations and a Review of Low-Affinity Fcgamma Receptor Polymorphisms in Control and Disease Populations
Blood,
December 15, 1999;
94(12):
4220 - 4232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Jain, S. Pu, P. S. Kalra, and S. P. Kalra
Evidence that Stimulation of Two Modalities of Pituitary Luteinizing Hormone Release in Ovarian Steroid-Primed Ovariectomized Rats May Involve Neuropeptide Y Y1 and Y4 Receptors
Endocrinology,
November 1, 1999;
140(11):
5171 - 5177.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. J. Morris and C. C. Malbon
Physiological Regulation of G Protein-Linked Signaling
Physiol Rev,
October 1, 1999;
79(4):
1373 - 1430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert
Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype
Endocrinology,
September 1, 1999;
140(9):
4046 - 4055.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Engler, E. Redei, and I. Kola
The Corticotropin-Release Inhibitory Factor Hypothesis: A Review of the Evidence for the Existence of Inhibitory as Well as Stimulatory Hypophysiotropic Regulation of Adrenocorticotropin Secretion and Biosynthesis
Endocr. Rev.,
August 1, 1999;
20(4):
460 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Iyengar, D. L. Li, and R. M. A. Simmons
Characterization of Neuropeptide Y-Induced Feeding in Mice: Do Y1-Y6 Receptor Subtypes Mediate Feeding?
J. Pharmacol. Exp. Ther.,
May 1, 1999;
289(2):
1031 - 1040.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Sun and R. J. Miller
Multiple Neuropeptide Y Receptors Regulate K+ and Ca2+ Channels in Acutely Isolated Neurons From the Rat Arcuate Nucleus
J Neurophysiol,
March 1, 1999;
81(3):
1391 - 1403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Smith, M. W. Walker, R. Artymyshyn, J. Bard, B. Borowsky, J. A. Tamm, W.-J. Yao, P. J.-J. Vaysse, T. A. Branchek, C. Gerald, et al.
Cloned Human and Rat Galanin GALR3 Receptors. PHARMACOLOGY AND ACTIVATION OF G-PROTEIN INWARDLY RECTIFYING K+ CHANNELS
J. Biol. Chem.,
September 4, 1998;
273(36):
23321 - 23326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dumont, A. Fournier, and R. Quirion
Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain
J. Neurosci.,
August 1, 1998;
18(15):
5565 - 5574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zukowska-Grojec, E. Karwatowska-Prokopczuk, W. Rose, J. Rone, S. Movafagh, H. Ji, Y. Yeh, W.-T. Chen, H. K. Kleinman, E. Grouzmann, et al.
Neuropeptide Y : A Novel Angiogenic Factor From the Sympathetic Nerves and Endothelium
Circ. Res.,
July 27, 1998;
83(2):
187 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Michel, A. Beck-Sickinger, H. Cox, H. N. Doods, H. Herzog, D. Larhammar, R. Quirion, T. Schwartz, and T. Westfall
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
Pharmacol. Rev.,
March 1, 1998;
50(1):
143 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Robidoux, L. Simoneau, S. St-Pierre, H. Ech-Chadli, and J. Lafond
Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis
Am J Physiol Endocrinol Metab,
March 1, 1998;
274(3):
E502 - E509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Ault, J. M. Radeff, and L. L. Werling
Modulation of [3H]Dopamine Release from Rat Nucleus Accumbens by Neuropeptide Y May Involve a Sigma1-like Receptor
J. Pharmacol. Exp. Ther.,
February 1, 1998;
284(2):
553 - 560.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Sun, L. H. Philipson, and R. J. Miller
Regulation of K+ and Ca++ Channels by a Family of Neuropeptide Y Receptors
J. Pharmacol. Exp. Ther.,
February 1, 1998;
284(2):
625 - 632.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Schwarzer, N. Kofler, and G. Sperk
Up-Regulation of Neuropeptide Y-Y2 Receptors in an Animal Model of Temporal Lobe Epilepsy
Mol. Pharmacol.,
January 1, 1998;
53(1):
6 - 13.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Jackerott and L.-I. Larsson
Immunocytochemical Localization of the NPY/PYY Y1 Receptor in Enteric Neurons, Endothelial Cells, and Endocrine-like Cells of the Rat Intestinal Tract
J. Histochem. Cytochem.,
December 1, 1997;
45(12):
1643 - 1650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zheng, P. Zhang, and T. D. Hexum
Neuropeptide Y Inhibits Chromaffin Cell Nicotinic Receptor-Stimulated Tyrosine Hydroxylase Activity through a Receptor-Linked G Protein-Mediated Process
Mol. Pharmacol.,
December 1, 1997;
52(6):
1027 - 1033.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Jackerott and L.-I. Larsson
Immunocytochemical Localization of the NPY/PYY Y1 Receptor in the Developing Pancreas
Endocrinology,
November 1, 1997;
138(11):
5013 - 5018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Small, D. G. A. Morgan, K. Meeran, M. M. Heath, I. Gunn, C. M. B. Edwards, J. Gardiner, G. M. Taylor, J. D. Hurley, M. Rossi, et al.
Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release
PNAS,
October 14, 1997;
94(21):
11686 - 11691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Leupen, L. M. Besecke, and J. E. Levine
Neuropeptide Y Y1-Receptor Stimulation Is Required for Physiological Amplification of Preovulatory Luteinizing Hormone Surges
Endocrinology,
July 1, 1997;
138(7):
2735 - 2739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Rhim, G. A. Kinney, P. J. Emmerson, and R. J. Miller
Regulation of Neurotransmission in the Arcuate Nucleus of the Rat by Different Neuropeptide Y Receptors
J. Neurosci.,
May 1, 1997;
17(9):
2980 - 2989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sheriff, William. T. Chance, Josef. E. Fischer, and A. Balasubramaniam
Neuropeptide Y Treatment and Food Deprivation Increase Cyclic AMP Response Element-Binding in Rat Hypothalamus
Mol. Pharmacol.,
April 1, 1997;
51(4):
597 - 604.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. M. Rose, J. S. Lynch, S. T. Frazier, S. M. Fisher, W. Chung, P. Battaglino, Z. Fathi, R. Leibel, and P. Fernandes
Molecular Genetic Analysis of a Human Neuropeptide Y Receptor. THE HUMAN HOMOLOG OF THE MURINE "Y5" RECEPTOR MAY BE A PSEUDOGENE
J. Biol. Chem.,
February 7, 1997;
272(6):
3622 - 3627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. O'Shea, D. G. A. Morgan, K. Meeran, C. M. B. Edwards, M. D. Turton, S. J. Choi, M. M. Heath, I. Gunn, G. M. Taylor, J. K. Howard, et al.
Neuropeptide Y Induced Feeding in the Rat Is Mediated by a Novel Receptor
Endocrinology,
January 1, 1997;
138(1):
196 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chen and A. N. van den Pol
Multiple NPY Receptors Coexist in Pre- and Postsynaptic Sites: Inhibition of GABA Release in Isolated Self-Innervating SCN Neurons
J. Neurosci.,
December 1, 1996;
16(23):
7711 - 7724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Matsumoto, T. Nomura, K. Momose, Y. Ikeda, Y. Kondou, H. Akiho, J. Togami, Y. Kimura, M. Okada, and T. Yamaguchi
Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species
J. Biol. Chem.,
November 1, 1996;
271(44):
27217 - 27220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gregor, Y. Feng, L. B. DeCarr, L. J. Cornfield, and M. L. McCaleb
Molecular Characterization of a Second Mouse Pancreatic Polypeptide Receptor and Its Inactivated Human Homologue
J. Biol. Chem.,
November 1, 1996;
271(44):
27776 - 27781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hu, B. T. Bloomquist, L. J. Cornfield, L. B. DeCarr, J. R. Flores-Riveros, L. Friedman, P. Jiang, L. Lewis-Higgins, Y. Sadlowski, J. Schaefer, et al.
Identification of a Novel Hypothalamic Neuropeptide Y Receptor Associated with Feeding Behavior
J. Biol. Chem.,
October 18, 1996;
271(42):
26315 - 26319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. van den Pol, K. Obrietan, G. Chen, and A. B. Belousov
Neuropeptide Y-Mediated Long-Term Depression of Excitatory Activity in Suprachiasmatic Nucleus Neurons
J. Neurosci.,
September 15, 1996;
16(18):
5883 - 5895.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Weinberg, D. J.S. Sirinathsinghji, C. P. Tan, L.-L. Shiao, N. Morin, M. R. Rigby, R. H. Heavens, D. R. Rapoport, M. L. Bayne, M. A. Cascieri, et al.
Cloning and Expression of a Novel Neuropeptide Y Receptor
J. Biol. Chem.,
July 12, 1996;
271(28):
16435 - 16438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gerald, M. W. Walker, P. J.-J. Vaysse, C. He, T. A. Branchek, and R. L. Weinshank
Expression Cloning and Pharmacological Characterization of a Human Hippocampal Neuropeptide Y/Peptide YY Y2 Receptor Subtype
J. Biol. Chem.,
November 10, 1995;
270(45):
26758 - 26761.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|